Hepatology and Acute Liver Failure
Alpha Bioresearch S.L. is involved in clinical research focused on severe liver disease, with particular attention to acute-on-chronic liver failure and severe alcoholic hepatitis.
- Acute-on-chronic liver failure (ACLF)
- Severe alcoholic hepatitis (sAH)
- Chronic liver disease
The sponsor’s research activity centers on patients with advanced hepatic decompensation and associated complications affecting liver function and overall clinical stability.
Organ Failure and Critical Care
The clinical landscape includes conditions marked by extrahepatic organ dysfunction, reflecting interest in complex cases involving multiple failing systems alongside liver impairment.
- Renal failure
- Neurological involvement
- Respiratory dysfunction
Research in this area addresses severe multisystem presentations where hepatic injury is accompanied by cardiovascular, coagulation, or brain-related complications.
Inflammation and Immune Modulation
Alpha Bioresearch S.L. also funds work in therapeutic areas linked to inflammatory control and immune support in advanced liver disease.
- Granulocyte colony-stimulating factor (G-CSF)
- Inflammatory response
- Host recovery mechanisms
This includes interest in interventions aimed at supporting patients with severe hepatic inflammation and systemic deterioration.
Pharmacotherapy for Advanced Hepatic Disease
The sponsor’s trial portfolio reflects a focus on medicinal approaches for difficult-to-treat liver conditions, including combination-based treatment strategies in advanced disease settings.
- TAK-242
- Combination therapy
- Supportive care in hepatic decompensation
Clinical interest extends to treatment options for patients with high-risk liver failure features and limited organ reserve.
